Antibodies to several citrullinated antigens are enriched in the joints of rheumatoid arthritis patients

Objective High titers of specific anti–citrullinated protein antibodies (ACPAs) are frequently present in the serum of rheumatoid arthritis (RA) patients, but their presence in synovial fluid is less well characterized. The purpose of this study was to compare the levels of antibody to 4 well‐define...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Arthritis and rheumatism 2010-01, Vol.62 (1), p.44-52
Hauptverfasser: Snir, Omri, Widhe, Mona, Hermansson, Monika, von Spee, Caroline, Lindberg, Johan, Hensen, Sanne, Lundberg, Karin, Engström, Åke, Venables, Patrick J. W., Toes, René E. M., Holmdahl, Rikard, Klareskog, Lars, Malmström, Vivianne
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 52
container_issue 1
container_start_page 44
container_title Arthritis and rheumatism
container_volume 62
creator Snir, Omri
Widhe, Mona
Hermansson, Monika
von Spee, Caroline
Lindberg, Johan
Hensen, Sanne
Lundberg, Karin
Engström, Åke
Venables, Patrick J. W.
Toes, René E. M.
Holmdahl, Rikard
Klareskog, Lars
Malmström, Vivianne
description Objective High titers of specific anti–citrullinated protein antibodies (ACPAs) are frequently present in the serum of rheumatoid arthritis (RA) patients, but their presence in synovial fluid is less well characterized. The purpose of this study was to compare the levels of antibody to 4 well‐defined citrullinated candidate RA autoantigens in serum and synovial fluid and to determine whether antibodies to one citrullinated antigen are dominant over another. Furthermore, we studied their relationships with mutated citrullinated vimentin (MCV), a newly identified RA‐specific serum assay, and the classic cyclic citrullinated peptide (CCP) in the synovial fluid of well‐defined HLA–DR groups. Methods Paired serum and synovial fluid samples from 290 RA patients and serum samples from 100 age‐ and sex‐matched healthy controls were analyzed for the presence of anti‐MCV and anti‐CCP antibodies and for reactivity to citrullinated fibrinogen, α‐enolase, type II collagen, and vimentin. A total of 219 of the 290 patients were genotyped for the HLA–DR shared epitope alleles. Results Significantly higher proportions of antibodies against all RA‐associated citrullinated antigens were found in synovial fluid as compared with serum. This was also true for the MCV and CCP responses but not for non–RA‐associated anti–tetanus toxoid antibodies. As expected, we found a high correlation between citrullinated vimentin and MCV responses. All synovial fluid ACPAs were predominantly associated with HLA–DRB1*04 alleles and were confined to the CCP+/MCV+ subset of patients. Conclusion MCV and CCP positivity represent a similar subset of RA patients, whereas ACPAs with different fine specificities fall into subgroups of anti‐CCP+/anti‐MCV+ patients. The levels of all specific ACPAs were elevated in synovial fluid, suggesting that there is local antibody production and/or retention of ACPAs at the site of inflammation governed by RA‐predisposing genes.
doi_str_mv 10.1002/art.25036
format Article
fullrecord <record><control><sourceid>proquest_swepu</sourceid><recordid>TN_cdi_swepub_primary_oai_swepub_ki_se_553943</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>733694968</sourcerecordid><originalsourceid>FETCH-LOGICAL-c6146-88c438305a31e715b82eb6713e7ce27c4626a6644d9451fd28e07fc8d03266e13</originalsourceid><addsrcrecordid>eNqN0ltrFDEUB_Agil1XH_wCkhcpgtPmPpPHpdYLFASpvoZs5kwn7exkTTKWfvtmnW37tOhTLvz-Scg5CL2l5IQSwk5tzCdMEq6eoQWVTFeEcvocLQghouJS0yP0KqXrsmRc8pfoiBHCteBsgfrVmP06tB4SzgEn-APRDtj5HKdh8KPN0GJbzBWMCdsIGMboXV92_YhzD_g6-DEnHDoce5g2NgdfEjH30Wef8NZmDwW8Ri86OyR4sx-X6Ofn88uzr9XF9y_fzlYXlVNUqKppnOANJ9JyCjWV64bBWtWUQ-2A1U4opqxSQrRaSNq1rAFSd65pCWdKAeVLVM3nplvYTmuzjX5j450J1pv91k2ZgZFy9wXF64N-G0P7FHoIUkY0bWomS_bjwewn_2tlQrwy02SoKF-v_4_f5N6welfNJTqeeXnG7wlSNhufHAyDHSFMydRC6iJr9m_JudJCq6bID7N0MaQUoXt8BCVm10umVM787aVi3-1PndYbaB_lQ_MU8H4PbHJ26KIdnU9PjnFelyoVdzq7Wz_A3eEbzerH5Xz1PRn94cw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>733694968</pqid></control><display><type>article</type><title>Antibodies to several citrullinated antigens are enriched in the joints of rheumatoid arthritis patients</title><source>MEDLINE</source><source>Access via Wiley Online Library</source><creator>Snir, Omri ; Widhe, Mona ; Hermansson, Monika ; von Spee, Caroline ; Lindberg, Johan ; Hensen, Sanne ; Lundberg, Karin ; Engström, Åke ; Venables, Patrick J. W. ; Toes, René E. M. ; Holmdahl, Rikard ; Klareskog, Lars ; Malmström, Vivianne</creator><creatorcontrib>Snir, Omri ; Widhe, Mona ; Hermansson, Monika ; von Spee, Caroline ; Lindberg, Johan ; Hensen, Sanne ; Lundberg, Karin ; Engström, Åke ; Venables, Patrick J. W. ; Toes, René E. M. ; Holmdahl, Rikard ; Klareskog, Lars ; Malmström, Vivianne</creatorcontrib><description>Objective High titers of specific anti–citrullinated protein antibodies (ACPAs) are frequently present in the serum of rheumatoid arthritis (RA) patients, but their presence in synovial fluid is less well characterized. The purpose of this study was to compare the levels of antibody to 4 well‐defined citrullinated candidate RA autoantigens in serum and synovial fluid and to determine whether antibodies to one citrullinated antigen are dominant over another. Furthermore, we studied their relationships with mutated citrullinated vimentin (MCV), a newly identified RA‐specific serum assay, and the classic cyclic citrullinated peptide (CCP) in the synovial fluid of well‐defined HLA–DR groups. Methods Paired serum and synovial fluid samples from 290 RA patients and serum samples from 100 age‐ and sex‐matched healthy controls were analyzed for the presence of anti‐MCV and anti‐CCP antibodies and for reactivity to citrullinated fibrinogen, α‐enolase, type II collagen, and vimentin. A total of 219 of the 290 patients were genotyped for the HLA–DR shared epitope alleles. Results Significantly higher proportions of antibodies against all RA‐associated citrullinated antigens were found in synovial fluid as compared with serum. This was also true for the MCV and CCP responses but not for non–RA‐associated anti–tetanus toxoid antibodies. As expected, we found a high correlation between citrullinated vimentin and MCV responses. All synovial fluid ACPAs were predominantly associated with HLA–DRB1*04 alleles and were confined to the CCP+/MCV+ subset of patients. Conclusion MCV and CCP positivity represent a similar subset of RA patients, whereas ACPAs with different fine specificities fall into subgroups of anti‐CCP+/anti‐MCV+ patients. The levels of all specific ACPAs were elevated in synovial fluid, suggesting that there is local antibody production and/or retention of ACPAs at the site of inflammation governed by RA‐predisposing genes.</description><identifier>ISSN: 0004-3591</identifier><identifier>ISSN: 1529-0131</identifier><identifier>EISSN: 1529-0131</identifier><identifier>DOI: 10.1002/art.25036</identifier><identifier>PMID: 20039432</identifier><identifier>CODEN: ARHEAW</identifier><language>eng</language><publisher>Hoboken: Wiley Subscription Services, Inc., A Wiley Company</publisher><subject>Adult ; Aged ; Aged, 80 and over ; Arthritis, Rheumatoid - genetics ; Arthritis, Rheumatoid - immunology ; Autoantibodies - blood ; Autoantigens - immunology ; Biological and medical sciences ; Biomarkers, Tumor - immunology ; Citrulline - chemistry ; Citrulline - immunology ; Collagen Type II - immunology ; Diseases of the osteoarticular system ; DNA-Binding Proteins - immunology ; Enzyme-Linked Immunosorbent Assay ; Female ; Fibrinogen - chemistry ; Fibrinogen - immunology ; Genotype ; HLA-DR Antigens - genetics ; HLA-DRB1 Chains ; Humans ; Inflammatory joint diseases ; Male ; Medical sciences ; MEDICIN ; Medicin och hälsovetenskap ; MEDICINE ; Middle Aged ; Mutation ; Peptides, Cyclic - immunology ; Phosphopyruvate Hydratase - immunology ; Synovial Fluid - immunology ; Tumor Suppressor Proteins - immunology ; Vimentin - chemistry ; Vimentin - genetics ; Vimentin - immunology ; Young Adult</subject><ispartof>Arthritis and rheumatism, 2010-01, Vol.62 (1), p.44-52</ispartof><rights>Copyright © 2010 by the American College of Rheumatology</rights><rights>2015 INIST-CNRS</rights><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c6146-88c438305a31e715b82eb6713e7ce27c4626a6644d9451fd28e07fc8d03266e13</citedby><cites>FETCH-LOGICAL-c6146-88c438305a31e715b82eb6713e7ce27c4626a6644d9451fd28e07fc8d03266e13</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fart.25036$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fart.25036$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>230,314,780,784,885,1417,27924,27925,45574,45575</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=22337945$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20039432$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://urn.kb.se/resolve?urn=urn:nbn:se:kth:diva-27250$$DView record from Swedish Publication Index$$Hfree_for_read</backlink><backlink>$$Uhttps://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-140009$$DView record from Swedish Publication Index$$Hfree_for_read</backlink><backlink>$$Uhttp://kipublications.ki.se/Default.aspx?queryparsed=id:120918725$$DView record from Swedish Publication Index$$Hfree_for_read</backlink></links><search><creatorcontrib>Snir, Omri</creatorcontrib><creatorcontrib>Widhe, Mona</creatorcontrib><creatorcontrib>Hermansson, Monika</creatorcontrib><creatorcontrib>von Spee, Caroline</creatorcontrib><creatorcontrib>Lindberg, Johan</creatorcontrib><creatorcontrib>Hensen, Sanne</creatorcontrib><creatorcontrib>Lundberg, Karin</creatorcontrib><creatorcontrib>Engström, Åke</creatorcontrib><creatorcontrib>Venables, Patrick J. W.</creatorcontrib><creatorcontrib>Toes, René E. M.</creatorcontrib><creatorcontrib>Holmdahl, Rikard</creatorcontrib><creatorcontrib>Klareskog, Lars</creatorcontrib><creatorcontrib>Malmström, Vivianne</creatorcontrib><title>Antibodies to several citrullinated antigens are enriched in the joints of rheumatoid arthritis patients</title><title>Arthritis and rheumatism</title><addtitle>Arthritis Rheum</addtitle><description>Objective High titers of specific anti–citrullinated protein antibodies (ACPAs) are frequently present in the serum of rheumatoid arthritis (RA) patients, but their presence in synovial fluid is less well characterized. The purpose of this study was to compare the levels of antibody to 4 well‐defined citrullinated candidate RA autoantigens in serum and synovial fluid and to determine whether antibodies to one citrullinated antigen are dominant over another. Furthermore, we studied their relationships with mutated citrullinated vimentin (MCV), a newly identified RA‐specific serum assay, and the classic cyclic citrullinated peptide (CCP) in the synovial fluid of well‐defined HLA–DR groups. Methods Paired serum and synovial fluid samples from 290 RA patients and serum samples from 100 age‐ and sex‐matched healthy controls were analyzed for the presence of anti‐MCV and anti‐CCP antibodies and for reactivity to citrullinated fibrinogen, α‐enolase, type II collagen, and vimentin. A total of 219 of the 290 patients were genotyped for the HLA–DR shared epitope alleles. Results Significantly higher proportions of antibodies against all RA‐associated citrullinated antigens were found in synovial fluid as compared with serum. This was also true for the MCV and CCP responses but not for non–RA‐associated anti–tetanus toxoid antibodies. As expected, we found a high correlation between citrullinated vimentin and MCV responses. All synovial fluid ACPAs were predominantly associated with HLA–DRB1*04 alleles and were confined to the CCP+/MCV+ subset of patients. Conclusion MCV and CCP positivity represent a similar subset of RA patients, whereas ACPAs with different fine specificities fall into subgroups of anti‐CCP+/anti‐MCV+ patients. The levels of all specific ACPAs were elevated in synovial fluid, suggesting that there is local antibody production and/or retention of ACPAs at the site of inflammation governed by RA‐predisposing genes.</description><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Arthritis, Rheumatoid - genetics</subject><subject>Arthritis, Rheumatoid - immunology</subject><subject>Autoantibodies - blood</subject><subject>Autoantigens - immunology</subject><subject>Biological and medical sciences</subject><subject>Biomarkers, Tumor - immunology</subject><subject>Citrulline - chemistry</subject><subject>Citrulline - immunology</subject><subject>Collagen Type II - immunology</subject><subject>Diseases of the osteoarticular system</subject><subject>DNA-Binding Proteins - immunology</subject><subject>Enzyme-Linked Immunosorbent Assay</subject><subject>Female</subject><subject>Fibrinogen - chemistry</subject><subject>Fibrinogen - immunology</subject><subject>Genotype</subject><subject>HLA-DR Antigens - genetics</subject><subject>HLA-DRB1 Chains</subject><subject>Humans</subject><subject>Inflammatory joint diseases</subject><subject>Male</subject><subject>Medical sciences</subject><subject>MEDICIN</subject><subject>Medicin och hälsovetenskap</subject><subject>MEDICINE</subject><subject>Middle Aged</subject><subject>Mutation</subject><subject>Peptides, Cyclic - immunology</subject><subject>Phosphopyruvate Hydratase - immunology</subject><subject>Synovial Fluid - immunology</subject><subject>Tumor Suppressor Proteins - immunology</subject><subject>Vimentin - chemistry</subject><subject>Vimentin - genetics</subject><subject>Vimentin - immunology</subject><subject>Young Adult</subject><issn>0004-3591</issn><issn>1529-0131</issn><issn>1529-0131</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqN0ltrFDEUB_Agil1XH_wCkhcpgtPmPpPHpdYLFASpvoZs5kwn7exkTTKWfvtmnW37tOhTLvz-Scg5CL2l5IQSwk5tzCdMEq6eoQWVTFeEcvocLQghouJS0yP0KqXrsmRc8pfoiBHCteBsgfrVmP06tB4SzgEn-APRDtj5HKdh8KPN0GJbzBWMCdsIGMboXV92_YhzD_g6-DEnHDoce5g2NgdfEjH30Wef8NZmDwW8Ri86OyR4sx-X6Ofn88uzr9XF9y_fzlYXlVNUqKppnOANJ9JyCjWV64bBWtWUQ-2A1U4opqxSQrRaSNq1rAFSd65pCWdKAeVLVM3nplvYTmuzjX5j450J1pv91k2ZgZFy9wXF64N-G0P7FHoIUkY0bWomS_bjwewn_2tlQrwy02SoKF-v_4_f5N6welfNJTqeeXnG7wlSNhufHAyDHSFMydRC6iJr9m_JudJCq6bID7N0MaQUoXt8BCVm10umVM787aVi3-1PndYbaB_lQ_MU8H4PbHJ26KIdnU9PjnFelyoVdzq7Wz_A3eEbzerH5Xz1PRn94cw</recordid><startdate>201001</startdate><enddate>201001</enddate><creator>Snir, Omri</creator><creator>Widhe, Mona</creator><creator>Hermansson, Monika</creator><creator>von Spee, Caroline</creator><creator>Lindberg, Johan</creator><creator>Hensen, Sanne</creator><creator>Lundberg, Karin</creator><creator>Engström, Åke</creator><creator>Venables, Patrick J. W.</creator><creator>Toes, René E. M.</creator><creator>Holmdahl, Rikard</creator><creator>Klareskog, Lars</creator><creator>Malmström, Vivianne</creator><general>Wiley Subscription Services, Inc., A Wiley Company</general><general>Wiley</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7QL</scope><scope>C1K</scope><scope>ADTPV</scope><scope>AOWAS</scope><scope>D8V</scope><scope>DF2</scope></search><sort><creationdate>201001</creationdate><title>Antibodies to several citrullinated antigens are enriched in the joints of rheumatoid arthritis patients</title><author>Snir, Omri ; Widhe, Mona ; Hermansson, Monika ; von Spee, Caroline ; Lindberg, Johan ; Hensen, Sanne ; Lundberg, Karin ; Engström, Åke ; Venables, Patrick J. W. ; Toes, René E. M. ; Holmdahl, Rikard ; Klareskog, Lars ; Malmström, Vivianne</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c6146-88c438305a31e715b82eb6713e7ce27c4626a6644d9451fd28e07fc8d03266e13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Arthritis, Rheumatoid - genetics</topic><topic>Arthritis, Rheumatoid - immunology</topic><topic>Autoantibodies - blood</topic><topic>Autoantigens - immunology</topic><topic>Biological and medical sciences</topic><topic>Biomarkers, Tumor - immunology</topic><topic>Citrulline - chemistry</topic><topic>Citrulline - immunology</topic><topic>Collagen Type II - immunology</topic><topic>Diseases of the osteoarticular system</topic><topic>DNA-Binding Proteins - immunology</topic><topic>Enzyme-Linked Immunosorbent Assay</topic><topic>Female</topic><topic>Fibrinogen - chemistry</topic><topic>Fibrinogen - immunology</topic><topic>Genotype</topic><topic>HLA-DR Antigens - genetics</topic><topic>HLA-DRB1 Chains</topic><topic>Humans</topic><topic>Inflammatory joint diseases</topic><topic>Male</topic><topic>Medical sciences</topic><topic>MEDICIN</topic><topic>Medicin och hälsovetenskap</topic><topic>MEDICINE</topic><topic>Middle Aged</topic><topic>Mutation</topic><topic>Peptides, Cyclic - immunology</topic><topic>Phosphopyruvate Hydratase - immunology</topic><topic>Synovial Fluid - immunology</topic><topic>Tumor Suppressor Proteins - immunology</topic><topic>Vimentin - chemistry</topic><topic>Vimentin - genetics</topic><topic>Vimentin - immunology</topic><topic>Young Adult</topic><toplevel>online_resources</toplevel><creatorcontrib>Snir, Omri</creatorcontrib><creatorcontrib>Widhe, Mona</creatorcontrib><creatorcontrib>Hermansson, Monika</creatorcontrib><creatorcontrib>von Spee, Caroline</creatorcontrib><creatorcontrib>Lindberg, Johan</creatorcontrib><creatorcontrib>Hensen, Sanne</creatorcontrib><creatorcontrib>Lundberg, Karin</creatorcontrib><creatorcontrib>Engström, Åke</creatorcontrib><creatorcontrib>Venables, Patrick J. W.</creatorcontrib><creatorcontrib>Toes, René E. M.</creatorcontrib><creatorcontrib>Holmdahl, Rikard</creatorcontrib><creatorcontrib>Klareskog, Lars</creatorcontrib><creatorcontrib>Malmström, Vivianne</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Environmental Sciences and Pollution Management</collection><collection>SwePub</collection><collection>SwePub Articles</collection><collection>SWEPUB Kungliga Tekniska Högskolan</collection><collection>SWEPUB Uppsala universitet</collection><jtitle>Arthritis and rheumatism</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Snir, Omri</au><au>Widhe, Mona</au><au>Hermansson, Monika</au><au>von Spee, Caroline</au><au>Lindberg, Johan</au><au>Hensen, Sanne</au><au>Lundberg, Karin</au><au>Engström, Åke</au><au>Venables, Patrick J. W.</au><au>Toes, René E. M.</au><au>Holmdahl, Rikard</au><au>Klareskog, Lars</au><au>Malmström, Vivianne</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Antibodies to several citrullinated antigens are enriched in the joints of rheumatoid arthritis patients</atitle><jtitle>Arthritis and rheumatism</jtitle><addtitle>Arthritis Rheum</addtitle><date>2010-01</date><risdate>2010</risdate><volume>62</volume><issue>1</issue><spage>44</spage><epage>52</epage><pages>44-52</pages><issn>0004-3591</issn><issn>1529-0131</issn><eissn>1529-0131</eissn><coden>ARHEAW</coden><abstract>Objective High titers of specific anti–citrullinated protein antibodies (ACPAs) are frequently present in the serum of rheumatoid arthritis (RA) patients, but their presence in synovial fluid is less well characterized. The purpose of this study was to compare the levels of antibody to 4 well‐defined citrullinated candidate RA autoantigens in serum and synovial fluid and to determine whether antibodies to one citrullinated antigen are dominant over another. Furthermore, we studied their relationships with mutated citrullinated vimentin (MCV), a newly identified RA‐specific serum assay, and the classic cyclic citrullinated peptide (CCP) in the synovial fluid of well‐defined HLA–DR groups. Methods Paired serum and synovial fluid samples from 290 RA patients and serum samples from 100 age‐ and sex‐matched healthy controls were analyzed for the presence of anti‐MCV and anti‐CCP antibodies and for reactivity to citrullinated fibrinogen, α‐enolase, type II collagen, and vimentin. A total of 219 of the 290 patients were genotyped for the HLA–DR shared epitope alleles. Results Significantly higher proportions of antibodies against all RA‐associated citrullinated antigens were found in synovial fluid as compared with serum. This was also true for the MCV and CCP responses but not for non–RA‐associated anti–tetanus toxoid antibodies. As expected, we found a high correlation between citrullinated vimentin and MCV responses. All synovial fluid ACPAs were predominantly associated with HLA–DRB1*04 alleles and were confined to the CCP+/MCV+ subset of patients. Conclusion MCV and CCP positivity represent a similar subset of RA patients, whereas ACPAs with different fine specificities fall into subgroups of anti‐CCP+/anti‐MCV+ patients. The levels of all specific ACPAs were elevated in synovial fluid, suggesting that there is local antibody production and/or retention of ACPAs at the site of inflammation governed by RA‐predisposing genes.</abstract><cop>Hoboken</cop><pub>Wiley Subscription Services, Inc., A Wiley Company</pub><pmid>20039432</pmid><doi>10.1002/art.25036</doi><tpages>9</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0004-3591
ispartof Arthritis and rheumatism, 2010-01, Vol.62 (1), p.44-52
issn 0004-3591
1529-0131
1529-0131
language eng
recordid cdi_swepub_primary_oai_swepub_ki_se_553943
source MEDLINE; Access via Wiley Online Library
subjects Adult
Aged
Aged, 80 and over
Arthritis, Rheumatoid - genetics
Arthritis, Rheumatoid - immunology
Autoantibodies - blood
Autoantigens - immunology
Biological and medical sciences
Biomarkers, Tumor - immunology
Citrulline - chemistry
Citrulline - immunology
Collagen Type II - immunology
Diseases of the osteoarticular system
DNA-Binding Proteins - immunology
Enzyme-Linked Immunosorbent Assay
Female
Fibrinogen - chemistry
Fibrinogen - immunology
Genotype
HLA-DR Antigens - genetics
HLA-DRB1 Chains
Humans
Inflammatory joint diseases
Male
Medical sciences
MEDICIN
Medicin och hälsovetenskap
MEDICINE
Middle Aged
Mutation
Peptides, Cyclic - immunology
Phosphopyruvate Hydratase - immunology
Synovial Fluid - immunology
Tumor Suppressor Proteins - immunology
Vimentin - chemistry
Vimentin - genetics
Vimentin - immunology
Young Adult
title Antibodies to several citrullinated antigens are enriched in the joints of rheumatoid arthritis patients
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T21%3A39%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_swepu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Antibodies%20to%20several%20citrullinated%20antigens%20are%20enriched%20in%20the%20joints%20of%20rheumatoid%20arthritis%20patients&rft.jtitle=Arthritis%20and%20rheumatism&rft.au=Snir,%20Omri&rft.date=2010-01&rft.volume=62&rft.issue=1&rft.spage=44&rft.epage=52&rft.pages=44-52&rft.issn=0004-3591&rft.eissn=1529-0131&rft.coden=ARHEAW&rft_id=info:doi/10.1002/art.25036&rft_dat=%3Cproquest_swepu%3E733694968%3C/proquest_swepu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=733694968&rft_id=info:pmid/20039432&rfr_iscdi=true